CLINICAL_TRIALS
trial_result
· 2015-09-23
Clinical Trial Update: Botulinum Toxin Injection to Prevent VT Storm [Phase 1]
Summary
Phase 1 clinical trial is evaluating botulinum toxin injections to prevent ventricular tachycardia storm; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: VT Storm | Phase 1 | Status: UNKNOWN